良性前列腺增生干预前后MRI评估:最新进展
本文综述了良性前列腺增生(BPH)各种微创手术治疗(包括激光剜除、光选择性汽化、水蒸气热疗、UroLift植入和前列腺动脉栓塞)后前列腺的MRI表现及解剖学改变。文章旨在帮助放射科医生熟悉BPH在MRI上的基础解剖变化,并描述术后MRI表现及并发症,同时指出新兴数据支持MRI在预测术后 outcomes 方面的作用。
要点
- 熟悉不同BPH微创手术后前列腺的MRI表现,有助于正确识别术后改变与并发症。
- UroLift植入后前列腺体积不缩小,而其他热消融或栓塞术会导致体积缩小。
- MRI目前不常规用于BPH术前评估,但可能有助于预测术后疗效。
关键影像表现/征象
- 激光剜除、光选择性汽化和水蒸气热疗等会导致尿道周围前列腺组织体积缩小。
- UroLift植入永久金属装置撑开前列腺尿道,但前列腺体积不缩小。
- 前列腺动脉栓塞导致前列腺整体体积缩小。
临床应用与阅片要点
- 阅片时应了解患者曾接受何种BPH手术,以正确解读术后MRI表现。
- 注意识别不同术后改变:体积缩小见于热消融或栓塞,UroLift则体积不变。
- 关注术后影像上的并发症表现。
局限性
- 本文为综述,未报告系统检索策略和纳入文献数量。
- MRI目前不常规用于BPH术前评估,其预测术后 outcomes 的作用基于新兴数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Transurethral resection of the prostate is the most commonly performed procedure for the management of patients with lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH). However, in recent years, various minimally invasive surgical therapies have been introduced to treat BPH. These include laser-based procedures such as holmium laser enucleation of the prostate and photoselective vaporization of the prostate as well as thermal ablation procedures such as water vapor thermal therapy (Rezūm), all of which result in volume reduction of periurethral prostatic tissue. In comparison, a permanent metallic device (UroLift) can be implanted to pull open the prostatic urethra without an associated decrease in prostate size, and selective catheter-directed prostate artery embolization results in a global decrease in prostate size. The goal of this article is to familiarize radiologists with the underlying anatomic changes that occur in BPH as visualized on MRI and to describe the appearance of the prostate on MRI performed after these procedures. Complications encountered on imaging after these procedures are also discussed. Although MRI is not currently used in the routine preprocedural evaluation of BPH, emerging data support a role for MRI in predicting postprocedure outcomes.
引用
- Diaz TA, Benson B, Clinkenbeard A, et al. MRI Evaluation of Patients Before and After Interventions for Benign Prostatic Hyperplasia: An Update. AJR Am J Roentgenol. 2021. PMID: 34259037. doi:10.2214/AJR.21.26278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。